Dyadic International (DYAI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
Meeting formally opened by the Chairman, with introductions of board members, executive team, auditors, and legal counsel.
Safe harbor disclosure regarding forward-looking statements and associated risks was provided.
Agenda included addressing shareholder proposals, voting, and a strategic update presentation.
Board and executive committee updates
Board members and executive officers in attendance were introduced, including the CEO, CFO, and COO.
Inspector of Elections and representatives from independent auditors and legal counsel were present.
Shareholder proposals
Four proposals were presented: election of a Class I director, approval of a reverse stock split, ratification of auditors, and advisory approval of executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Dyadic International
- Facing potential Nasdaq delisting for bid price and equity deficiencies, with a hearing planned.DYAI
Proxy filing18 Jun 2026 - Commercial stage reached with six product launches, global distribution, and early recurring revenues.DYAI
Lytham Partners Spring 2026 Investor Conference28 May 2026 - Commercializing animal-free proteins with scalable platforms and recurring revenues across key markets.DYAI
Sidoti Micro-Cap Virtual Conference20 May 2026 - Commercial-stage protein innovator drives growth with animal-free products and global partnerships.DYAI
Investor presentation20 May 2026 - Q1 2026 revenue rose 182% to $1.11M, with net loss narrowing and global expansion underway.DYAI
Q1 202619 May 2026 - Shareholders will vote on director election, reverse stock split, auditor ratification, and executive pay.DYAI
Proxy filing12 May 2026 - C1 platform delivers rapid, high-yield, animal-free biologics with proven safety and global validation.DYAI
Investor presentation1 May 2026 - Virtual meeting to vote on director, reverse split, auditor, and executive pay; board urges approval.DYAI
Proxy filing1 May 2026 - Net loss widened to $7.36M on lower revenue, with expanded commercialization and partnerships.DYAI
Q4 202525 Mar 2026